nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Etoposide—uterine cancer	0.32	0.542	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—uterine cancer	0.27	0.458	CbGbCtD
Trisalicylate-choline—Skin papilloma—Progesterone—uterine cancer	0.0177	0.0564	CcSEcCtD
Trisalicylate-choline—PTGS1—oviduct—uterine cancer	0.0141	0.147	CbGeAlD
Trisalicylate-choline—PTGS1—artery—uterine cancer	0.00934	0.0972	CbGeAlD
Trisalicylate-choline—PTGS2—artery—uterine cancer	0.00892	0.0929	CbGeAlD
Trisalicylate-choline—Stupor—Progesterone—uterine cancer	0.00771	0.0246	CcSEcCtD
Trisalicylate-choline—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.00758	0.0242	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Progesterone—uterine cancer	0.00628	0.0201	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Progesterone—uterine cancer	0.00556	0.0177	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00518	0.0165	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Progesterone—uterine cancer	0.00515	0.0164	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Dactinomycin—uterine cancer	0.00444	0.0142	CcSEcCtD
Trisalicylate-choline—PTGS2—myometrium—uterine cancer	0.00431	0.0449	CbGeAlD
Trisalicylate-choline—Oesophagitis—Dactinomycin—uterine cancer	0.00372	0.0119	CcSEcCtD
Trisalicylate-choline—Asthma—Progesterone—uterine cancer	0.00361	0.0115	CcSEcCtD
Trisalicylate-choline—PTGS1—epithelium—uterine cancer	0.00354	0.0369	CbGeAlD
Trisalicylate-choline—PTGS1—uterine cervix—uterine cancer	0.00351	0.0365	CbGeAlD
Trisalicylate-choline—Abdominal discomfort—Progesterone—uterine cancer	0.00346	0.011	CcSEcCtD
Trisalicylate-choline—PTGS1—smooth muscle tissue—uterine cancer	0.00341	0.0355	CbGeAlD
Trisalicylate-choline—PTGS2—epithelium—uterine cancer	0.00338	0.0352	CbGeAlD
Trisalicylate-choline—PTGS2—uterine cervix—uterine cancer	0.00335	0.0349	CbGeAlD
Trisalicylate-choline—Pain—Carboplatin—uterine cancer	0.00334	0.0107	CcSEcCtD
Trisalicylate-choline—Weight increased—Progesterone—uterine cancer	0.00329	0.0105	CcSEcCtD
Trisalicylate-choline—PTGS1—renal system—uterine cancer	0.00328	0.0342	CbGeAlD
Trisalicylate-choline—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.0104	CcSEcCtD
Trisalicylate-choline—PTGS2—smooth muscle tissue—uterine cancer	0.00326	0.0339	CbGeAlD
Trisalicylate-choline—Drowsiness—Progesterone—uterine cancer	0.00322	0.0103	CcSEcCtD
Trisalicylate-choline—PTGS1—endometrium—uterine cancer	0.00317	0.0331	CbGeAlD
Trisalicylate-choline—PTGS2—renal system—uterine cancer	0.00314	0.0327	CbGeAlD
Trisalicylate-choline—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.01	CcSEcCtD
Trisalicylate-choline—PTGS1—mammalian vulva—uterine cancer	0.00307	0.032	CbGeAlD
Trisalicylate-choline—PTGS2—endometrium—uterine cancer	0.00303	0.0316	CbGeAlD
Trisalicylate-choline—Lethargy—Dactinomycin—uterine cancer	0.00301	0.00962	CcSEcCtD
Trisalicylate-choline—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.0095	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Epirubicin—uterine cancer	0.00294	0.0094	CcSEcCtD
Trisalicylate-choline—Hypothermia—Epirubicin—uterine cancer	0.00294	0.0094	CcSEcCtD
Trisalicylate-choline—PTGS1—uterus—uterine cancer	0.00293	0.0305	CbGeAlD
Trisalicylate-choline—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.00931	CcSEcCtD
Trisalicylate-choline—Hepatitis—Progesterone—uterine cancer	0.00289	0.00922	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Epirubicin—uterine cancer	0.00284	0.00906	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Etoposide—uterine cancer	0.00281	0.00897	CcSEcCtD
Trisalicylate-choline—PTGS2—uterus—uterine cancer	0.0028	0.0291	CbGeAlD
Trisalicylate-choline—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.00893	CcSEcCtD
Trisalicylate-choline—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00878	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Progesterone—uterine cancer	0.00273	0.00872	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Doxorubicin—uterine cancer	0.00272	0.00869	CcSEcCtD
Trisalicylate-choline—Hypothermia—Doxorubicin—uterine cancer	0.00272	0.00869	CcSEcCtD
Trisalicylate-choline—Tinnitus—Progesterone—uterine cancer	0.00269	0.0086	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Etoposide—uterine cancer	0.00269	0.00859	CcSEcCtD
Trisalicylate-choline—PTGS1—female reproductive system—uterine cancer	0.00263	0.0274	CbGeAlD
Trisalicylate-choline—Gastric ulcer—Doxorubicin—uterine cancer	0.00263	0.00839	CcSEcCtD
Trisalicylate-choline—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00836	CcSEcCtD
Trisalicylate-choline—Erythema—Progesterone—uterine cancer	0.00252	0.00803	CcSEcCtD
Trisalicylate-choline—PTGS2—female reproductive system—uterine cancer	0.00251	0.0262	CbGeAlD
Trisalicylate-choline—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.0079	CcSEcCtD
Trisalicylate-choline—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00779	CcSEcCtD
Trisalicylate-choline—PTGS1—female gonad—uterine cancer	0.00239	0.0249	CbGeAlD
Trisalicylate-choline—PTGS1—vagina—uterine cancer	0.00238	0.0248	CbGeAlD
Trisalicylate-choline—Burning sensation—Epirubicin—uterine cancer	0.00237	0.00758	CcSEcCtD
Trisalicylate-choline—PTGS2—female gonad—uterine cancer	0.00229	0.0238	CbGeAlD
Trisalicylate-choline—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00728	CcSEcCtD
Trisalicylate-choline—PTGS2—vagina—uterine cancer	0.00227	0.0237	CbGeAlD
Trisalicylate-choline—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00713	CcSEcCtD
Trisalicylate-choline—Burning sensation—Doxorubicin—uterine cancer	0.0022	0.00701	CcSEcCtD
Trisalicylate-choline—Confusional state—Progesterone—uterine cancer	0.00207	0.00661	CcSEcCtD
Trisalicylate-choline—Oedema—Progesterone—uterine cancer	0.00205	0.00655	CcSEcCtD
Trisalicylate-choline—Hepatitis—Dactinomycin—uterine cancer	0.00204	0.00652	CcSEcCtD
Trisalicylate-choline—Stinging—Epirubicin—uterine cancer	0.00204	0.0065	CcSEcCtD
Trisalicylate-choline—Shock—Progesterone—uterine cancer	0.00202	0.00645	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Progesterone—uterine cancer	0.00198	0.00634	CcSEcCtD
Trisalicylate-choline—Anorexia—Progesterone—uterine cancer	0.00196	0.00625	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Dactinomycin—uterine cancer	0.00193	0.00616	CcSEcCtD
Trisalicylate-choline—Hypotension—Progesterone—uterine cancer	0.00192	0.00612	CcSEcCtD
Trisalicylate-choline—Flushing—Dactinomycin—uterine cancer	0.0019	0.00605	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—uterine cancer	0.00188	0.00602	CcSEcCtD
Trisalicylate-choline—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00599	CcSEcCtD
Trisalicylate-choline—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00594	CcSEcCtD
Trisalicylate-choline—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00584	CcSEcCtD
Trisalicylate-choline—Somnolence—Progesterone—uterine cancer	0.00182	0.00583	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Progesterone—uterine cancer	0.00181	0.00577	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—uterine cancer	0.0018	0.00575	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00574	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Progesterone—uterine cancer	0.00178	0.0057	CcSEcCtD
Trisalicylate-choline—Erythema—Dactinomycin—uterine cancer	0.00178	0.00568	CcSEcCtD
Trisalicylate-choline—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00566	CcSEcCtD
Trisalicylate-choline—Constipation—Progesterone—uterine cancer	0.00176	0.0056	CcSEcCtD
Trisalicylate-choline—Pain—Progesterone—uterine cancer	0.00176	0.0056	CcSEcCtD
Trisalicylate-choline—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00555	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Progesterone—uterine cancer	0.00169	0.0054	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—uterine cancer	0.00167	0.00532	CcSEcCtD
Trisalicylate-choline—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00528	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—uterine cancer	0.00164	0.00524	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00523	CcSEcCtD
Trisalicylate-choline—Urticaria—Progesterone—uterine cancer	0.00163	0.00521	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00516	CcSEcCtD
Trisalicylate-choline—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00508	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—uterine cancer	0.00158	0.00503	CcSEcCtD
Trisalicylate-choline—PTGS1—lymph node—uterine cancer	0.00154	0.016	CbGeAlD
Trisalicylate-choline—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00489	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—uterine cancer	0.00152	0.00484	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—uterine cancer	0.00151	0.00481	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—uterine cancer	0.00149	0.00476	CcSEcCtD
Trisalicylate-choline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00472	CcSEcCtD
Trisalicylate-choline—PTGS2—lymph node—uterine cancer	0.00147	0.0153	CbGeAlD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—uterine cancer	0.00146	0.00465	CcSEcCtD
Trisalicylate-choline—Pruritus—Progesterone—uterine cancer	0.00145	0.00464	CcSEcCtD
Trisalicylate-choline—Oedema—Dactinomycin—uterine cancer	0.00145	0.00463	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Progesterone—uterine cancer	0.0014	0.00448	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Etoposide—uterine cancer	0.0014	0.00446	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—uterine cancer	0.00139	0.00445	CcSEcCtD
Trisalicylate-choline—Anorexia—Dactinomycin—uterine cancer	0.00138	0.00442	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—uterine cancer	0.00138	0.00441	CcSEcCtD
Trisalicylate-choline—Flushing—Etoposide—uterine cancer	0.00137	0.00438	CcSEcCtD
Trisalicylate-choline—Dizziness—Progesterone—uterine cancer	0.00136	0.00433	CcSEcCtD
Trisalicylate-choline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.0042	CcSEcCtD
Trisalicylate-choline—Vomiting—Progesterone—uterine cancer	0.00131	0.00417	CcSEcCtD
Trisalicylate-choline—Rash—Progesterone—uterine cancer	0.00129	0.00413	CcSEcCtD
Trisalicylate-choline—Dermatitis—Progesterone—uterine cancer	0.00129	0.00413	CcSEcCtD
Trisalicylate-choline—Headache—Progesterone—uterine cancer	0.00129	0.00411	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00406	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dactinomycin—uterine cancer	0.00126	0.00403	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Etoposide—uterine cancer	0.00126	0.00402	CcSEcCtD
Trisalicylate-choline—Pain—Dactinomycin—uterine cancer	0.00124	0.00396	CcSEcCtD
Trisalicylate-choline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00393	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—uterine cancer	0.00122	0.0039	CcSEcCtD
Trisalicylate-choline—Nausea—Progesterone—uterine cancer	0.00122	0.00389	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dactinomycin—uterine cancer	0.0012	0.00382	CcSEcCtD
Trisalicylate-choline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00378	CcSEcCtD
Trisalicylate-choline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00374	CcSEcCtD
Trisalicylate-choline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00374	CcSEcCtD
Trisalicylate-choline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00372	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—uterine cancer	0.00113	0.00361	CcSEcCtD
Trisalicylate-choline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00353	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—uterine cancer	0.00109	0.00349	CcSEcCtD
Trisalicylate-choline—Confusional state—Etoposide—uterine cancer	0.00106	0.00338	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—uterine cancer	0.00104	0.0033	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Etoposide—uterine cancer	0.00102	0.00324	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—uterine cancer	0.00101	0.00323	CcSEcCtD
Trisalicylate-choline—Anorexia—Etoposide—uterine cancer	0.001	0.0032	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dactinomycin—uterine cancer	0.000993	0.00317	CcSEcCtD
Trisalicylate-choline—Hypotension—Etoposide—uterine cancer	0.000981	0.00313	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—uterine cancer	0.000958	0.00306	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—uterine cancer	0.000942	0.00301	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—uterine cancer	0.000934	0.00298	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—uterine cancer	0.000923	0.00295	CcSEcCtD
Trisalicylate-choline—Vomiting—Dactinomycin—uterine cancer	0.000922	0.00295	CcSEcCtD
Trisalicylate-choline—Rash—Dactinomycin—uterine cancer	0.000915	0.00292	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—uterine cancer	0.000913	0.00291	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—uterine cancer	0.000898	0.00287	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—uterine cancer	0.000898	0.00287	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—uterine cancer	0.000885	0.00282	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—uterine cancer	0.000872	0.00278	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—uterine cancer	0.000871	0.00278	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—uterine cancer	0.000865	0.00276	CcSEcCtD
Trisalicylate-choline—Nausea—Dactinomycin—uterine cancer	0.000862	0.00275	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—uterine cancer	0.000854	0.00273	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—uterine cancer	0.000834	0.00266	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—uterine cancer	0.000829	0.00265	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—uterine cancer	0.000819	0.00261	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—uterine cancer	0.000805	0.00257	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—uterine cancer	0.000783	0.0025	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—uterine cancer	0.000772	0.00247	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—uterine cancer	0.000769	0.00245	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—uterine cancer	0.000767	0.00245	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—uterine cancer	0.000743	0.00237	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—uterine cancer	0.000725	0.00231	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—uterine cancer	0.000721	0.0023	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—uterine cancer	0.000718	0.00229	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—uterine cancer	0.000715	0.00228	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—uterine cancer	0.000711	0.00227	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—uterine cancer	0.000706	0.00225	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—uterine cancer	0.000694	0.00222	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—uterine cancer	0.000668	0.00213	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—uterine cancer	0.000667	0.00213	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—uterine cancer	0.000662	0.00211	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—uterine cancer	0.000661	0.00211	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—uterine cancer	0.000658	0.0021	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—uterine cancer	0.000654	0.00209	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—uterine cancer	0.000624	0.00199	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—uterine cancer	0.000594	0.00189	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—uterine cancer	0.000589	0.00188	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—uterine cancer	0.000579	0.00185	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—uterine cancer	0.000569	0.00182	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—uterine cancer	0.000561	0.00179	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—uterine cancer	0.00055	0.00176	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—uterine cancer	0.000549	0.00175	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—uterine cancer	0.000545	0.00174	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—uterine cancer	0.000536	0.00171	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000527	0.00168	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—uterine cancer	0.000523	0.00167	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—uterine cancer	0.000519	0.00166	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—uterine cancer	0.000518	0.00165	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—uterine cancer	0.000512	0.00163	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—uterine cancer	0.000509	0.00162	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—uterine cancer	0.000503	0.00161	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—uterine cancer	0.000503	0.00161	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—uterine cancer	0.000485	0.00155	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—uterine cancer	0.000484	0.00155	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—uterine cancer	0.000479	0.00153	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—uterine cancer	0.000473	0.00151	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—uterine cancer	0.000468	0.00149	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—uterine cancer	0.000466	0.00149	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—uterine cancer	0.000466	0.00149	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—uterine cancer	0.000449	0.00143	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—uterine cancer	0.000433	0.00138	CcSEcCtD
Trisalicylate-choline—Pruritus—Epirubicin—uterine cancer	0.000416	0.00133	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—uterine cancer	0.000403	0.00129	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—uterine cancer	0.000389	0.00124	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—uterine cancer	0.000385	0.00123	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—uterine cancer	0.000374	0.00119	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—uterine cancer	0.000373	0.00119	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—uterine cancer	0.000371	0.00118	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—uterine cancer	0.000371	0.00118	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—uterine cancer	0.000369	0.00118	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—uterine cancer	0.00036	0.00115	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—uterine cancer	0.00035	0.00112	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—uterine cancer	0.000346	0.00111	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—uterine cancer	0.000343	0.0011	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—uterine cancer	0.000343	0.0011	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—uterine cancer	0.000341	0.00109	CcSEcCtD
Trisalicylate-choline—Nausea—Doxorubicin—uterine cancer	0.000324	0.00103	CcSEcCtD
